Marshall Wace, LLP Shattuck Labs, Inc. Transaction History

Marshall Wace, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.56 - $11.18 $30,092 - $94,504	-8,453 Reduced 10.91%	69,042 $266,000
Q1 2024 May 15, 2024	BUY	$7.37 - $10.09 $571,138 - $781,924	77,495 New	77,495 $692,000
Q1 2022 May 16, 2022	SELL	$4.22 - $8.89 $1.08 Million - $2.27 Million	-255,003 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.36 - $21.08 $2.13 Million - $5.38 Million	255,003 New	255,003 $2.17 Million

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $46.6M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.